Significance of the Wiscott Aldrich Syndrome study for case follow-up. A documentary review
DOI:
https://doi.org/10.35381/s.v.v3i6.345Keywords:
Wiscott Aldrich syndrome, Immunodeficiency, Bleeding disorders, Hematological Mechanisms.Abstract
Within medical practices, a number of diseases can be detected, and will depend on the great expertise of the doctor to differentiate them from those concomitant diseases or symptoms. In the case of immunodeficiencies, the doctor's job to be able to observe symptoms is one of the decisive factors so that the treatment provided is appropriate and appropriate. The purpose of this article is to carry out a documentary review of Wiscott Aldrich Syndrome in order to establish its importance, and allow further study and follow-up of the Case. The registration of information for the development of this review was made based on the parameters described by the P-PRISMA check list, which marks the functional structure of an article based on data collection through computer and bibliographic platforms. In the case of immunodeficiencies, especially Wiskott-Aldrich Syndrome, making it visible is a crucial part so that the health system is updated and allows access to the various treatments that help minimize symptoms and study protocols for a treatment therapeutic.
Downloads
References
Blancas L, Escamilla C, Yamazaki M. Síndrome De Wiskott-Aldrich; revisión actualizada. Alerg México. 2011;58(4):213–8.
Ariga T. Wiskott-Aldrich Syndrome; An X-Linked Primary Immunodeficiency Disease with Unique and Characteristic Features. Allergol Int [Internet]. 2012 Jan 1 [cited 2019 Jan 20];61(2):183–9. Available from: https://www.sciencedirect.com/science/article/pii/S1323893015302124
Zaldívar G. Caracterización molecular de pacientes con e síndrome de Wiskott-Aldrich y reconstitución funcional con inhibidores de la calpaína y el proteasoma [Internet]. Universidad de Granada ; 2009 [cited 2019 Jan 18]. Available from: https://hera.ugr.es/tesisugr/18197942.pdf
Cleland SY, Siegel RM, Williams R, Flügel A, Just W. Wiskott-Aldrich Syndrome at the nexus of autoimmune and primary immunodeficiency diseases. 2011 [cited 2018 Nov 21]; Available from: https://febs.onlinelibrary.wiley.com/doi/pdf/10.1016/j.febslet.2011.10.031
Sáchez A, Martín F. Síndorme de Wiskott-Aldrich: Modelos celulares humanos para estudios preclínicos de vectores lentivirales para terapia genética [Internet]. Universidad de Granada; 2017. Available from: http://hdl.handle.net/10481/45266
Mount Sinai. Mount Sinaí expert guides: Allergy and clinical Inmunology. John Wiley. Sampson H, editor. John Wiley and Son; 2015.
GEISER, IntraMed. Guía de recursos en efermedades raras [Internet]. Buenos Aires; 2011. Available from: http://www.nobleseguros.com/ARTICULOS_SEGURIDAD_DEL_PACIENTE/40.pdf
Sánchez Gilabert A. Síndrome de Wiskott - Aldrich: Modelos celulares humanos para esudios preclínicos de vectores lentivirales para terapia génica. 2017 Feb 17 [cited 2018 Nov 21]; Available from: http://digibug.ugr.es/handle/10481/45266
Koldej R, Carney G, Weilgosz M, Zhou S, Zhan J, Sorrentino B. The Comparison of Various Promoters for Wiskott Aldrich Syndrome Gene Therapy Using Insulated Lentiviral Vectors. Hum Gene Ther Clin Dev [Internet]. 2013 May 1 [cited 2018 Nov 22];24(2):77–85. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1525001616368289
Anton I. Identifican la proteína WIP, clave en la progresión de los tumores - El médico interactivo : El médico interactivo [Internet]. El medico interactivo. 2016 [cited 2019 Jan 20]. Available from: http://elmedicointeractivo.com/identifican-proteina-wip-clave-progresion-tumores-20161219154546107964/
Sociedad Argentina de Hematología. Hematologia: Volumen 20 - Número Educacional - XII Congreso Argentino de ... - Sociedad Argentina de Hematologia - Google Libros [Internet]. 2016 [cited 2018 Nov 21]. 334 p. Available from: https://books.google.es/books?hl=es&lr=lang_es&id=3AsnDQAAQBAJ&oi=fnd&pg=PA116&dq=wiskott+aldrich&ots=uC7evJfC5s&sig=5N3lrVL4dZGrsYHPoxP3s-t7SUQ#v=onepage&q=wiskott aldrich&f=false
Sociedad Española de Terapia Génica y Celular. Proteína WAS y sus mutaciones [Internet]. Wiskott-Aldrich Syndrome. 2016 [cited 2019 Jan 20]. Available from: https://wiskottaldrichsyndrome.weebly.com/wasp-prot.html
Jaime C, Cañarte J, Moreira R, Lucas El. Factores de riesgo asociado a enfermedades alergicas en la población infantil de Manta. Primera. Manta: Casa editora del pozo; 2018.
Mayorga AJ, Martinez R, Notarangelo LD, Pai S, Mayorga LF, Juan M, et al. Síndrome de wiskott-aldrich. dificultades diagnósticas y terapéuticas de un paciente con inmunodeficiencia primaria. Rev médica Honduras. 2017;85(1–2):27–9.
Castiello MC, Scaramuzza S, Pala F, Ferrua F, Uva P, Brigida I, et al. B-cell reconstitution after lentiviral vector–mediated gene therapy in patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol [Internet]. 2015 Sep [cited 2018 Nov 21];136(3):692-702.e2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25792466
Miskin J, Gurruchaga J, Fenelon G, Boulet S, Jan C, Bonvento G, et al. Gene Therapy with Lentiviral Vector Transduced CD34+ Cells for the Treatment of Wiskott-Aldrich Syndrome. Mol Ther [Internet]. 2011;19:S231. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1525001616371775
Jiménez RO, Sánchez GI, Matínez ME, Hernández MC. Regeneracónn celular utilizando el virus de inmunodeficiencia humana en el tratamiento de dos enfermedades genéticas. Rev Cubana Hig Epidemiol. 2006;44(1):1–14.
Cañarte Alcívar J, Marín Tello C, Rivera Chavez L, Fernandez Sanchez P, Huerta Vicuña R. El conocimiento en el sistema de salud. CienciaDigital [Internet]. 5may2019 [citado 10may2019];3(2):508-1. Available from: http://cienciadigital.org/revistacienciadigital2/index.php/CienciaDigital/article/view/447
Cañarte Alcívar J, Anzules Guerra J, Uscocovich Alcívar A, Bravo Mendoza M, Zambrano Mera S, Bello Mendoza V, Vazquez Y. Importancia de la inmunología como ciencia. CienciaDigital [Internet]. 1jul.2018 [citado 01may2019];2(3):28-9. Available from: http://cienciadigital.org/revistacienciadigital2/index.php/CienciaDigital/article/view/135
Published
How to Cite
Issue
Section
License
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.
